LIQUID COMPOSITION COMPRISING IBUPROFEN AND PHENYLEPHRINE

The present invention relates to a liquid pharmaceutical composition for oral administration in the form of suspension which comprises the combination of ibuprofen and phenylephrine, or a pharmaceutically acceptable salt thereof, as active substances, and hypromellose, xanthan gum, liquid maltitol,...

Full description

Saved in:
Bibliographic Details
Main Authors Sanz Menéndez, Nuria, Vicario De La Torre, Marta, Sánchez García, José Ángel, Iglesias Sánchez, José Carlos, Sante Serna, Luis
Format Patent
LanguageCroatian
English
Published 12.04.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to a liquid pharmaceutical composition for oral administration in the form of suspension which comprises the combination of ibuprofen and phenylephrine, or a pharmaceutically acceptable salt thereof, as active substances, and hypromellose, xanthan gum, liquid maltitol, glycerine and water. The composition is stable, has good organoleptical properties and shows excellent pharmacokinetic profile, providing quick absorption of the drugs. The present invention also relates to the use of the composition for treating the symptoms of flu and common cold, particularly in adults and in children over 7 years.
AbstractList The present invention relates to a liquid pharmaceutical composition for oral administration in the form of suspension which comprises the combination of ibuprofen and phenylephrine, or a pharmaceutically acceptable salt thereof, as active substances, and hypromellose, xanthan gum, liquid maltitol, glycerine and water. The composition is stable, has good organoleptical properties and shows excellent pharmacokinetic profile, providing quick absorption of the drugs. The present invention also relates to the use of the composition for treating the symptoms of flu and common cold, particularly in adults and in children over 7 years.
Author Sante Serna, Luis
Vicario De La Torre, Marta
Sánchez García, José Ángel
Iglesias Sánchez, José Carlos
Sanz Menéndez, Nuria
Author_xml – fullname: Sanz Menéndez, Nuria
– fullname: Vicario De La Torre, Marta
– fullname: Sánchez García, José Ángel
– fullname: Iglesias Sánchez, José Carlos
– fullname: Sante Serna, Luis
BookMark eNrjYmDJy89L5WSw9PEMDPV0UXD29w3wD_YM8fT3A7ODPIM9_dwVPJ1CA4L83Vz9FBz9XBQCPFz9In1cAzyCPP1ceRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJvEdQgJGBkYmBoYFFSIihMXGqAIB3LFU
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate TEKUĆI SASTAV KOJI SADRŽI IBUPROFEN I FENILEFRIN
ExternalDocumentID HRP20240108TT1
GroupedDBID EVB
ID FETCH-epo_espacenet_HRP20240108TT13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:48:44 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Croatian
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_HRP20240108TT13
Notes Application Number: HRP20240108T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240412&DB=EPODOC&CC=HR&NR=P20240108T1
ParticipantIDs epo_espacenet_HRP20240108TT1
PublicationCentury 2000
PublicationDate 20240412
PublicationDateYYYYMMDD 2024-04-12
PublicationDate_xml – month: 04
  year: 2024
  text: 20240412
  day: 12
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies Nutra Essential OTC, S.L
RelatedCompanies_xml – name: Nutra Essential OTC, S.L
Score 3.5235088
Snippet The present invention relates to a liquid pharmaceutical composition for oral administration in the form of suspension which comprises the combination of...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title LIQUID COMPOSITION COMPRISING IBUPROFEN AND PHENYLEPHRINE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240412&DB=EPODOC&locale=&CC=HR&NR=P20240108T1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8BhT1Dedih9TCkrfistsOvtQxLapjWxp7DqZT6PdMhRhG1vFv28SOufT3i45OC4hl_vKXQBupZGrskfSLRF4atlo4liuyIWFJlOMJnlLOI6qRu4xJx7YL0M8rMHXuhZG9wn90c0RpUSNpbyX-r5ebIJYoX5buborPuXU_DHKvNCsvGOpnmzUNkPfIzwJk8AMAi9OTZZ6XCNR6yGTrtKOsqNVo33y5quylMV_nRIdwi6X5GblEdQ-lg3YD9ZfrzVgr1dlvCVYCd_qGNwufR3Q0AiSHk_6VMWWNJzSPmXPBvUHPE0iwownFho8Juy9S3icUkZO4CYiWRBbkofR34pHcbrhN0P3p1CfzWfiDIx2pyhyjIspcsa2cHPXlae86OB2jjs5cvA5NLdRutiOvoQDNbJ0K8Mm1Mvlt7iSOrcsrvVe_QIugYAy
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED-GivNNp-LH1ILSt-Iym9Y-FHH9MNE2jV0n82m0W4cibGOr-O-bhM35tLcjB8cl5HIfyf0CcCOCXHl7JNKSEo8NE40swynz0kCjMUajvFValuxGjplFeuZzH_dr8LXqhVE4oT8KHFFY1FDYe6XO69m6iOWrt5WL2-JTDE0fwsz19WV2LNyTidq633EDnviJp3ueS1KdpS5XTNS6z0SqtG1LeF4ZO711ZFvK7L9PCfdhhwtxk-oAah_zBtS91ddrDdiNlzfeglwa3-IQnIi-9qiveUnMky6VtSVFp7RL2ZNGOz2eJmHAtEfma5wE7D0KOEkpC47gOgwyjxhCh8HfjAckXeubobtj2JpMJ-UJaG27KHKMizGyhmbp5I4jdnlh43aO7RxZ-BSamySdbWZfQZ1kcTSIKHs5hz3JMRSsYRO2qvl3eSH8b1VcqnX7BVXYgx8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=LIQUID+COMPOSITION+COMPRISING+IBUPROFEN+AND+PHENYLEPHRINE&rft.inventor=Sanz+Men%C3%A9ndez%2C+Nuria&rft.inventor=Vicario+De+La+Torre%2C+Marta&rft.inventor=S%C3%A1nchez+Garc%C3%ADa%2C+Jos%C3%A9+%C3%81ngel&rft.inventor=Iglesias+S%C3%A1nchez%2C+Jos%C3%A9+Carlos&rft.inventor=Sante+Serna%2C+Luis&rft.date=2024-04-12&rft.externalDBID=T1&rft.externalDocID=HRP20240108TT1